Vaccine Manufacture and Supply – News and Features

The current standard for women receiving the human papillomavirus (HPV) vaccine is a three-dose regimen, however, a randomized controlled trial of 2,275 women in Kenya has shown that a single dose was highly effective.

A study has analyzed a quarter-century of national survey data to better understand how social, economic and geographical inequalities in India shaped the chances of children remaining unvaccinated between 1992 and 2016.

Speciality vaccine company Valneva has announced topline results from its Phase III trial of the inactivated, adjuvanted COVID-19 vaccine candidate VLA2001.

Bioelectronic assays extend our ability to quickly study interactions between cells, viruses, and therapeutics in real time over days, in one plate, without interference by labels or tags. This article highlights how the effect of various therapeutics on the cell-killing behavior of SARS-CoV-2 was assessed using a bioelectronic assay.

This article explores the concept of vaccine stockpiling, and how genomic surveillance and mathematical modeling can help us to understand its potential impact on the SARS-CoV-2 virus and the pandemic response.

The need for new vaccines for HIV, Tuberculosis (TB) and malaria are all the greater after the pandemic, but will vaccine advances for SARS-CoV-2 help? Anthony King explores for Technology Networks.

Technology Networks spoke with UNICEF about the challenges in achieving vaccine equality, what factors contribute to low immunization rates, how we can work to make vaccines available to marginalized communities and the consequences of vaccine inequality.

Sachin Rawat explores the concept of vaccine booster shots, how they are manufactured and when their administration is appropriate, with insights from experts in immunology.

A peer-reviewed analysis of US national survey data of 75,000 adults shows, from early January to late March, a near “18 percentage point” increase of adults who have either had the COVID-19 vaccine jab or are willing to do have it.

The UK and Australia will share COVID-19 vaccine doses to benefit each other’s life-saving vaccine rollout programs.